1.40Open1.10Pre Close49 Volume267 Open Interest76.00Strike Price5.67KTurnover47.15%IV2.30%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry1.35Extrinsic Value100Contract SizeAmericanOptions Type-0.4430Delta0.1058Gamma59.93Leverage Ratio-0.1976Theta-0.0035Rho-26.55Eff Leverage0.0313Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet